Evidence Guides

These are the pages that are not about a single compound. They cover the three things that decide whether a supplement decision goes well or badly: whether it is safe alongside what you already take, how the industry constructs the claim that got you here, and what the label in your hand actually discloses. None of these pages carries a product link, which is deliberate — a page about a safety concern should not have a commercial interest in the outcome.

Safety and interactions

This is the group most people skip and the one that most often matters. Supplement-drug interactions are under-reported rather than rare: the botanicals sold for cognition include cholinesterase inhibitors, antiplatelet agents, CYP enzyme modulators and compounds that alter thyroid hormone absorption, and none of that appears on a sales page. The failure mode is almost never a dramatic reaction on day one. It is an INR that drifts, a levothyroxine dose that stops holding, or a sedative effect that accumulates across three products nobody counted together.

If you take prescription medication, read the relevant page here before the dosage page for whatever you are considering — and then have the conversation with a pharmacist, who can see your full list and will do this for free.

How the industry sells

Brain supplement marketing follows a template, and once you have seen the template you cannot unsee it: a single hero ingredient with an origin story, an institutional association that turns out to be decorative, a proprietary blend at undisclosed doses, bulk pricing behind a refund guarantee, and a layer of press-release “reviews” syndicated across newswire sites to fill the search results. Understanding the structure is more protective than memorising any individual verdict, because the formulas change and the structure does not.

We publish this group despite carrying affiliate links elsewhere on the site, and we are aware of how that reads. The alternative — knowing how the sales machinery works and not writing it down — is worse.

How to read a label

Most of the distance between a trial and a capsule is created on the label, legally and in plain sight. Per-capsule versus per-serving. Powder versus extract, and an extract ratio that describes a manufacturing process rather than a concentration of anything you care about. Standardization to a marker compound that is not the active one. A certification mark that verifies identity and purity, and says nothing whatsoever about whether the contents work.

The habit worth building is simple: find the trial dose first, then check whether the label lets you confirm you are getting it. If the answer is no, the price is irrelevant.

What is missing here, and will be

This index grows as we publish, and a stale index is worse than none — so we would rather it be short and accurate. Guides in progress include the anatomy of a brain-supplement sales video, and the current legal status of NMN, which reversed in September 2025 and is unstable enough that we will not publish it until we can date-stamp it properly. When a guide is not here, it is because we have not written it, not because it is hiding behind an email form.

Related reading

These statements have not been evaluated by the Food and Drug Administration. Nothing here is intended to diagnose, treat, cure or prevent any disease.

This article is information, not medical advice. Talk to a doctor or pharmacist about your own situation, especially if you take prescription medication.